Hanna T. Gazda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hanna T. Gazda has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Adrianna Vlachos
Division of Pediatric Hematology/Oncology and Stem Cell Transplantation, Albert Einstein College of Medicine, Schneider Children's Hospital, New Hyde Park, NY, USA
1 shared publication- Alan H. Beggs
Division of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
1 shared publication Anna Ploszynska
Department of Paediatric Haematology and Oncology, University Medical School, Gdansk
1 shared publicationCharlotte M. Niemeyer
Division of Paediatric Haematology and Oncology, Department of Paediatrics, University of Freiburg, Freiburg, Germany
1 shared publicationColin A. Sieff
Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston
1 shared publicationDagmar Pospisilova
Department of Paediatrics, University Hospital, Olomouc, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 2 September 2004
- Published by Wiley in British Journal of Haematology
- Vol. 127 (1) , 105-113
RNA and protein evidence for haplo‐insufficiency in Diamond–Blackfan anaemia patients with RPS19 mutations
Summary: The genetic basis of Diamond–Blackfan anaemia (DBA), a congenital erythroid hypoplasia that shows marked clinical heterogeneity, remains obscure. However, the fact that nearly one‐quarter of patients harbour a variety of mutations in RPS19, a ribosomal protein gene, provides an opportunity to examine whether haplo‐insufficiency of RPS19 protein can be demonstrated in certain cases. To that end, we identified 19 of 81 DBA index cases, both familial and sporadic, with RPS19 mutations. We found 14 distinct insertions, deletions, missense, nonsense and splice site mutations in the 19 probands, and studied mutations in 10 patients at the RNA level and in three patients at the protein level. Characterization of the mutations in 10 probands, including six with novel insertions, nonsense and splice site mutations, showed that the abnormal transcript was detectable in nine cases. The RPS19 mRNA and protein in CD34+ bone marrow cells identified haplo‐insufficiency in three cases predicted to have one functional allele. Our data support the notion that, in addition to rare DBA patients with the deletion of one allele, the disease in certain other RPS19 mutant patients is because of RPS19 protein haplo‐insufficiency.
- 2 September 2004
- Published by Wiley in British Journal of Haematology
- Vol. 127 (1) , 105-113
Open AccessRNA and protein evidence for haplo‐insufficiency in Diamond–Blackfan anaemia patients with RPS19 mutations
Summary: The genetic basis of Diamond–Blackfan anaemia (DBA), a congenital erythroid hypoplasia that shows marked clinical heterogeneity, remains obscure. However, the fact that nearly one‐quarter of patients harbour a variety of mutations in RPS19, a ribosomal protein gene, provides an opportunity to examine whether haplo‐insufficiency of RPS19 protein can be demonstrated in certain cases. To that end, we identified 19 of 81 DBA index cases, both familial and sporadic, with RPS19 mutations. We found 14 distinct insertions, deletions, missense, nonsense and splice site mutations in the 19 probands, and studied mutations in 10 patients at the RNA level and in three patients at the protein level. Characterization of the mutations in 10 probands, including six with novel insertions, nonsense and splice site mutations, showed that the abnormal transcript was detectable in nine cases. The RPS19 mRNA and protein in CD34+ bone marrow cells identified haplo‐insufficiency in three cases predicted to have one functional allele. Our data support the notion that, in addition to rare DBA patients with the deletion of one allele, the disease in certain other RPS19 mutant patients is because of RPS19 protein haplo‐insufficiency.